Page last updated: 2024-08-18

2-naphthol and hs 1793

2-naphthol has been researched along with hs 1793 in 18 studies

Research

Studies (18)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (16.67)29.6817
2010's14 (77.78)24.3611
2020's1 (5.56)2.80

Authors

AuthorsStudies
Chung, HY; Chung, SW; Ha, YM; Lee, H; Song, S; Suh, H1
Jeong, SH; Jo, WS; Kwon, TK; Leem, SH; Seol, SY; Song, S; Suh, H; Yoo, YH1
Jeong, NY; Jeong, SH; Kim, TH; Kwon, TK; Lee, JS; Park, BS; Song, S; Suh, H; Yoo, KS; Yoo, YH1
Bae, JH; Jeong, NY; Kwon, TK; Park, JW; Suh, H; Um, HJ; Yoo, YH1
Choi, YH; Jeong, NY; Lee, JS; Lee, SY; Rho, JH; Song, S; Suh, H; Yoo, KS; Yoo, YH; Yoon, YG1
Choi, YJ; Jeong, MH; Jo, WS; Kim, SD; Lee, CM; Lee, SH; Ryu, SR; Seo, SY; Suh, Hs; Yang, KM; Yoo, YH1
Choi, YJ; Jeong, MH; Jo, WS; Kim, HJ; Park, YS; Son, CH; Suh, HS; Yang, KM; Yun, JH1
Han, J; Jeong, SH; Kim, HK; Kim, N; Ko, KS; Lee, SR; Rhee, BD; Song, IS; Song, S; Suh, H; Yoo, YH; Yoon, YG1
Han, J; Hanh, TM; Jeong, SH; Kim, HK; Kim, N; Ko, KS; Lee, SR; Noh, SJ; Rhee, BD; Song, IS; Song, S; Suh, H1
Choi, YH; Chung, HY; Hossain, MA; Kim, DH; Kim, GY; Kim, JA; Kim, MY; Kim, ND; Suh, HS; Yoon, JH1
Chung, HY; Hossain, MA; Jeong, TC; Kim, DH; Kim, JA; Kim, MY; Kim, ND; Suh, H; Sung, B; Yoon, JH1
Jeong, DH; Jeong, MH; Jeong, SK; Jo, WS; Jo, YR; Lee, CG; Lee, KW; Oh, SJ; Yang, KM1
Choi, YJ; Jeong, MH; Jeong, SK; Jo, WS; Lee, CW; Lee, KY; Oh, SJ; Park, YS; Yang, K1
Choi, YJ; Heo, K; Jeong, MH; Park, HS; Yang, KM1
Chung, HY; Jung, JH; Kim, DH; Kim, MJ; Kim, ND; Suh, H; Sung, B1
Choi, YH; Chung, HY; Hwang, NL; Hwang, SY; Im, E; Kang, YJ; Kim, DH; Kim, JA; Kim, ND; Suh, H; Sung, B1
Ha, NC; Han, J; Jang, SW; Jeong, SH; Jeong, YJ; Kim, HK; Ko, KS; Rhee, BD; Shim, S; Shin, M; Song, IS1
Jeong, MH; Jeong, SK; Jo, WS; Kang, YR; Kim, JS; Lee, CG; Oh, SJ1

Other Studies

18 other study(ies) available for 2-naphthol and hs 1793

ArticleYear
4-(6-Hydroxy-2-naphthyl)-1,3-bezendiol: a potent, new tyrosinase inhibitor.
    Biological & pharmaceutical bulletin, 2007, Volume: 30, Issue:9

    Topics: Agaricales; Animals; Cell Survival; Dose-Response Relationship, Drug; Enzyme Inhibitors; Hydroquinones; Kinetics; Melanins; Melanoma, Experimental; Mice; Monophenol Monooxygenase; Naphthalenes; Naphthols; Phenols; Pyrones; Resorcinols; Resveratrol; Stilbenes

2007
A novel resveratrol derivative, HS1793, overcomes the resistance conferred by Bcl-2 in human leukemic U937 cells.
    Biochemical pharmacology, 2009, Apr-15, Volume: 77, Issue:8

    Topics: Antineoplastic Agents; Apoptosis; Cell Nucleus; Cell Survival; Drug Resistance, Neoplasm; Flow Cytometry; Humans; Immunoprecipitation; Membrane Potential, Mitochondrial; Methylation; Mitochondria; Molecular Structure; Naphthols; Proto-Oncogene Proteins c-bcl-2; Resorcinols; Resveratrol; Reverse Transcriptase Polymerase Chain Reaction; Stilbenes; U937 Cells

2009
A novel resveratrol analogue HS-1793 treatment overcomes the resistance conferred by Bcl-2 and is associated with the formation of mature PML nuclear bodies in renal clear cell carcinoma Caki-1 cells.
    International journal of oncology, 2009, Volume: 35, Issue:6

    Topics: Antineoplastic Agents; Apoptosis; Carcinoma, Renal Cell; Cell Line, Tumor; Drug Resistance, Neoplasm; Flow Cytometry; Fluorescent Antibody Technique; Humans; Intranuclear Inclusion Bodies; Kidney Neoplasms; Leukemia, Promyelocytic, Acute; Membrane Potential, Mitochondrial; Microscopy, Confocal; Naphthols; Nuclear Proteins; Promyelocytic Leukemia Protein; Proto-Oncogene Proteins c-bcl-2; Resorcinols; Resveratrol; Stilbenes; Transcription Factors; Tumor Suppressor Proteins

2009
Differential effects of resveratrol and novel resveratrol derivative, HS-1793, on endoplasmic reticulum stress-mediated apoptosis and Akt inactivation.
    International journal of oncology, 2010, Volume: 36, Issue:4

    Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Calcium; Caspase Inhibitors; Caspases, Initiator; Cell Proliferation; Cysteine Proteinase Inhibitors; DNA-Binding Proteins; Dose-Response Relationship, Drug; Endoplasmic Reticulum; Endoplasmic Reticulum Chaperone BiP; Enzyme Activation; Heat-Shock Proteins; HT29 Cells; Humans; Naphthols; Phosphorylation; Proto-Oncogene Proteins c-akt; Regulatory Factor X Transcription Factors; Resorcinols; Resveratrol; RNA Splicing; RNA, Messenger; Signal Transduction; Stilbenes; Stress, Physiological; Transcription Factor CHOP; Transcription Factors; X-Box Binding Protein 1

2010
The novel resveratrol analog HS-1793-induced polyploid LNCaP prostate cancer cells are vulnerable to downregulation of Bcl-xL.
    International journal of oncology, 2011, Volume: 38, Issue:6

    Topics: Antineoplastic Agents; Apoptosis; Aurora Kinase B; Aurora Kinases; bcl-X Protein; Cell Line, Tumor; Cell Survival; Down-Regulation; Drug Synergism; HCT116 Cells; Humans; K562 Cells; Male; Naphthols; Polyploidy; Prostatic Neoplasms; Protein Serine-Threonine Kinases; Resorcinols; U937 Cells

2011
Resveratrol analog, HS-1793 enhance anti-tumor immunity by reducing the CD4+CD25+ regulatory T cells in FM3A tumor bearing mice.
    International immunopharmacology, 2012, Volume: 14, Issue:3

    Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Survival; Female; Mice; Mice, Inbred C3H; Naphthols; Neoplasms; Resorcinols; Spleen; T-Lymphocytes; Tumor Burden

2012
The novel resveratrol analogue HS-1793 induces apoptosis via the mitochondrial pathway in murine breast cancer cells.
    International journal of oncology, 2012, Volume: 41, Issue:5

    Topics: Animals; Antineoplastic Agents; Apoptosis; Breast Neoplasms; Caspase 3; Cell Line, Tumor; Cell Survival; Cytochromes c; Female; G1 Phase; Membrane Potential, Mitochondrial; Mice; Mitochondria; Naphthols; Poly(ADP-ribose) Polymerases; Resorcinols; Signal Transduction

2012
An analogue of resveratrol HS-1793 exhibits anticancer activity against MCF-7 cells via inhibition of mitochondrial biogenesis gene expression.
    Molecules and cells, 2012, Volume: 34, Issue:4

    Topics: Antineoplastic Agents; Caspases; Cell Survival; Down-Regulation; Drug Screening Assays, Antitumor; Gene Expression Regulation, Neoplastic; Humans; MCF-7 Cells; Membrane Potential, Mitochondrial; Mitochondrial Proteins; Mitochondrial Turnover; Naphthols; Oxidative Phosphorylation; Resorcinols; Resveratrol; Stilbenes

2012
HS-1793, a recently developed resveratrol analogue protects rat heart against hypoxia/reoxygenation injury via attenuating mitochondrial damage.
    Bioorganic & medicinal chemistry letters, 2013, Jul-15, Volume: 23, Issue:14

    Topics: Animals; Calcium; Heart; Hypoxia; Mitochondria; Myocardial Reperfusion Injury; Naphthols; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Resorcinols; Resveratrol; Stilbenes

2013
A novel resveratrol analogue, HS-1793, inhibits hypoxia-induced HIF-1α and VEGF expression, and migration in human prostate cancer cells.
    International journal of oncology, 2013, Volume: 43, Issue:6

    Topics: Cell Hypoxia; Cell Line, Tumor; Cell Movement; Cell Survival; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Male; Naphthols; Neovascularization, Pathologic; Prostatic Neoplasms; Resorcinols; Signal Transduction; Vascular Endothelial Growth Factor A

2013
HS-1793, a resveratrol analogue, induces cell cycle arrest and apoptotic cell death in human breast cancer cells.
    International journal of oncology, 2014, Volume: 44, Issue:2

    Topics: Apoptosis; Biomarkers, Tumor; Blotting, Western; Breast Neoplasms; Caspases; Cell Cycle Checkpoints; Cell Proliferation; Female; Flow Cytometry; Humans; Immunoprecipitation; Naphthols; Resorcinols; Tumor Cells, Cultured

2014
Protective activity of a novel resveratrol analogue, HS-1793, against DNA damage in 137Cs-irradiated CHO-K1 cells.
    Journal of radiation research, 2014, Volume: 55, Issue:3

    Topics: Animals; Cell Survival; Cesium Radioisotopes; CHO Cells; Cricetinae; Cricetulus; DNA Damage; Dose-Response Relationship, Drug; Naphthols; Radiation Dosage; Radiation Tolerance; Radiation-Protective Agents; Resorcinols

2014
Interferon gamma induced by resveratrol analog, HS-1793, reverses the properties of tumor associated macrophages.
    International immunopharmacology, 2014, Volume: 22, Issue:2

    Topics: Animals; Cell Line, Tumor; Cell Movement; Female; Interferon-gamma; Macrophages; Mice; Mice, Inbred C3H; Naphthols; Neoplasm Invasiveness; Neoplasms; Resorcinols; Resveratrol; Stilbenes

2014
The resveratrol analog HS-1793 enhances radiosensitivity of mouse-derived breast cancer cells under hypoxic conditions.
    International journal of oncology, 2016, Volume: 49, Issue:4

    Topics: Animals; Antineoplastic Agents, Phytogenic; Blotting, Western; Cell Movement; Cell Survival; Enzyme-Linked Immunosorbent Assay; Female; Hypoxia; Mammary Neoplasms, Experimental; Mice; Mice, Inbred C3H; Microscopy, Fluorescence; Naphthols; Neoplastic Stem Cells; Neovascularization, Pathologic; Radiation Tolerance; Radiation-Sensitizing Agents; Real-Time Polymerase Chain Reaction; Resorcinols; Resveratrol; Stilbenes; Tumor Cells, Cultured

2016
Resveratrol analogue, HS-1793, induces apoptotic cell death and cell cycle arrest through downregulation of AKT in human colon cancer cells.
    Oncology reports, 2017, Volume: 37, Issue:1

    Topics: Antineoplastic Agents; Apoptosis; Cell Cycle Checkpoints; Cell Proliferation; Chromones; Colonic Neoplasms; Cytochromes c; Down-Regulation; Extracellular Signal-Regulated MAP Kinases; HCT116 Cells; Humans; Morpholines; Naphthols; Phosphorylation; Proto-Oncogene Proteins c-akt; Resorcinols; Resveratrol; Stilbenes

2017
HS-1793, a resveratrol analogue, downregulates the expression of hypoxia-induced HIF-1 and VEGF and inhibits tumor growth of human breast cancer cells in a nude mouse xenograft model.
    International journal of oncology, 2017, Volume: 51, Issue:2

    Topics: Animals; Cell Proliferation; Female; Gene Expression Regulation, Neoplastic; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; MCF-7 Cells; Mice; Naphthols; Resorcinols; Triple Negative Breast Neoplasms; Vascular Endothelial Growth Factor A; Xenograft Model Antitumor Assays

2017
Pharmacologic inhibition of AKT leads to cell death in relapsed multiple myeloma.
    Cancer letters, 2018, 09-28, Volume: 432

    Topics: Aged; Animals; Apoptosis; Cell Proliferation; Female; Gene Expression Regulation, Neoplastic; HSP90 Heat-Shock Proteins; Humans; Mice; Mice, Inbred NOD; Mice, SCID; Multiple Myeloma; Naphthols; Neoplasm Recurrence, Local; NF-kappa B; Phosphorylation; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-akt; Resorcinols; Signal Transduction; Tumor Cells, Cultured; Xenograft Model Antitumor Assays

2018
The resveratrol analogue, HS‑1793, enhances the effects of radiation therapy through the induction of anti‑tumor immunity in mammary tumor growth.
    International journal of oncology, 2020, Volume: 56, Issue:6

    Topics: Animals; Cell Line, Tumor; Cell Proliferation; Cell Survival; Chemoradiotherapy; Concanavalin A; Female; Interleukin-10; Mammary Neoplasms, Experimental; Mice; Naphthols; Radiation-Sensitizing Agents; Resorcinols; T-Lymphocytes, Regulatory; Transforming Growth Factor beta; Treatment Outcome; Xenograft Model Antitumor Assays

2020